Landauer — Q1 FY2014 Earnings Presentation
27 slides from Landauer's earnings presentation, Feb 6, 2014
Slide 1: Investor Presentation January 2014
LANDAUER Respect . Innovation Investor Presentation Honesty January 2014 Reliability
Slide 2: Safe Harbor Statement
LANDAUER Safe Harbor Stateme Some of the information shared here (including, in particular, the section titled “Fiscal 2014 Outlook") constitutes forward-looking ‘statements that are based on assumptions and involve certain risks and uncertainties. These include the following, without limitation: as
Slide 3: Landauer Today
LANDAUER Landauer Today The Global Leader in Radiation Science and Services Business Facts * Based in Glenwood, IL LANDAUER * Approximately 650 employees * Founded in 1954 * Global Platform and Infrastructure * 73,000 annual customers served; 1.8M annual individuals served * 94%+ Customer retention
Slide 4: Radiation Management is Becoming More Complex
LANDAUER Radiation Management is Becoming More Complex New Standards Patient Safety and Tougher State National Public Policy and Federal Regulations Healthcare Consolidation Regulatory Trends * CTPA, MA, RI, TX Evolving Treatments Acquisitions Partnerships Advanced radiation treatment choices and co
Slide 5: Radiation Risk Not Managed Consistently
LANDAUER Radiation Risk Not Managed Consistently Medical Imaging Risks Radiation Oncology Risks Employee Monitoring Risks Incomplete or unknown patient Radiation over/under —dose, Gaps in radiation safety training dose benchmarking & CT protocol imprecise delivery or unintended review exposure due t
Slide 6: Enterprise-Wide Radiation Safety Assessment
LANDAUER Enterprise-Wide Radiation Safety Assessment Core Business Complementary Acquisitions The Only Enterprise-Wide Medical Medical eae Ehvsics Radiation Safety Solution Provider Occupational Imaging : ; Monitoring/Patient Physics/Therapy abe iyy/ Diagnostic ee i Accessories Monitoring Physics Ma
Slide 7: Attractive Niche Business Model — Annuity Focused
LANDAUER Attractive Niche Business Model — Annuity Focused Strong, Stable Core Complementary Targeted Business with Growth Growth Businesses Adjacencies Opportunities Medical Medical [STUTReTay LEeayele Physics Products Army 9 ; 9 ; 90 % Annuity 90% Annuity 100% Service Service Gensumables 10% Equip
Slide 8: Driving Strong Cash Flows
LANDAUER Driving Strong Cash Flows Revenue, Net Income & Cash Flow f 2006, 2007 2008 2009 2010 2011, 2012 mm Revenue jp NetIncome — mg Cash Flow @ Cash Flow Margin Note: “Fiscal 2009Net Income exclides $1.8Mofter-toxiinpact ofcharges **Fiscal 2012 Net income includes §24.1Mpretoxrestcucturing, acqui
Slide 9: Generating Robust Dividend Payments
LANDAUER d Generating Robust Dividend Payments Sep-04 Sep-05 Sep-06 Sep-07 Sep-08 Sep-09 Sep-10 Sep-11 Sep-12Sep-13 e 4 2 a 4 mm Annual Dividend per Share ——Avg Dividend Yield
Slide 10: Executing On Segment Strategies
LANDAUER Executing On Segment Strategies Optimize Core Deliver Sustainable Se ro Maximize Tota and Maximize Total Shareholder Returns
Slide 11: Radiation Measurement Strategic Initiatives
LANDAUER Radiation Measurement Radiation Measurement Strategic Initiatives Optimize Competitive Strategic the Core Growth Expansion O Management/Structure + SBU structure announced FY 2012 + EMEA Management Structure Announced Q4 FY2013 + Globalization/Shared Services Efficiency OIT Platform Enhance
Slide 12: Medical Physics Strategic Initiatives
LANDAUER Medical Physics Strategic Initiatives Optimize Competitive Strategic the Core Growth Expansion (O Management/Structure O Hospital Group (O Business Development - + Refined Management Structure Purchasing Interest + Practice Group Acquisitions Medical FY2012 2011 to C to Curent + Tied to Ent
Slide 13: Medical Products Strategic Initiatives
LANDAUER Medical Products Strategic Initiatives Optimize Competitive Strategic the Core Growth Expansion (CO Management/Structure O Revenue Pipeline O Business Development + Professional / Experienced Expansion + Assessing companies/new Medical Device Management + $8M currently technologies Lanai CO
Slide 14: Q1 FY 2014 Highlights
LANDAUER Q1 FY 2014 Highlights Optimize Competitive Strategic the Core Growth Expansion + New Customer Enhancements + Radwatch military sales of + New Microstar system Functionality $2.4M in QLFY 2014 generates $1M in FY 2013 + More than 11,000 customers on new online system/ 3,000 on legacy system
Slide 15: Q1 FY 2014 Highlights
LANDAUER Q1 FY 2014 Highlights For workers required to manually manipulate or work in close proximity to radioactive ‘materials and radiation producing equipment. Saturn™ MicroStar 2 “Extremity Radiation Monitoring Ring” “Patient Dose Data Management”
Slide 16: Q1 FY 2014 Highlights
LANDAUER Q1 FY 2014 Highlights Radiation Measurement Innovative New Annuity Service Offerings RadFacts™ Year to Date Performance Retrieve valuable spiarreyiaacsa SiaBiak saieiban Soe information through Dosimeters Dosimeters [ALARA Performance myLDR’s enhanced dashboard functionality. Here are new t
Slide 17: Q1 FY 2014 Highlights
LANDAUER Q1 FY 2014 Highlights System #1 System #2 Next Pipeline + SAM+ — Proposed Q2 Start + S4M — Proposed Q2 Start + System's Top 21= $29.7M + 12 Hospitals, 9 Cancer Centers, 12 Imaging + 18 Hospitals, 7 Cancer Centers — (not including Systems #1 & #2) Centers + AllModalities- Imaging, Radiation
Slide 18: Q1 FY 2014 Highlights
LANDAUER Q1 FY 2014 Highlights IZI Medical Products Quick Spherz® is a new product that will save you setup time while giving you the same level of accuracy as you have today. Spherz have played an integral role in image- guided procedures performed worldwide. Our proven track record positions IZI a
Slide 19: Financial Overview
LANDAUER Respect Innovation Honesty Reliability Financial Overview
Slide 20: Landauer Financial Overview
LANDAUER Landauer Financial Overview (Sin millions, FYE 9/30) subscription and is recurring in nature ™ Contract with U.S. military to replace its antiquated radiation monitoring system provides opportunities to expand to other global military and first responder markets $152.4 | $150.2 Strategic ex
Slide 21: Revenue and Adjusted EBITDA; Q1 FY14 Financial Highlights
LANDAUER Revenue ai 2014 a1 2013 mi Rad Measurement m Med Physics mi Med Products Adjusted EBITDA $14 s12 s10 $8 $6 $4 $2 Millions 15t Q FY14 Financial Highlights $0 a1 2014 a1 2013 Revenue of $37.7 million in the first quarter of fiscal 2014. Operating income of $5.0 million versus $6.7 million in
Slide 22: FY 2012 Through FY 2014 Key Drivers
pane §FY 2012 Through FY 2014 Key Drivers FY 2012—FY 2013 Drivers = Military Radwatch Revenue: 2012 Actual $4.4M; 2013 Actual S8.1M; 2014 Guidance $2.3M; 2014 Opportunty$12.0% = ITPlatform Enhanceme 1 $4.6M additional expense in 2013 vs. 2012: $2.3M depreciation &S2.3MIT & Customer Service expense +
Slide 23: Fiscal Year 2014 Outlook
LANDAUER Fiscal Year 2014 Outlook FY 2014 Outlook vs. FY 2013 Actual ™ Expected Revenue $140 to ™ Risks associated with $160 million military funding for the " Adjusted EBITDA of $46 to Radwatch product in 2014 $49 million ™ Non-cash Stock Based Compensation Expense: = Net IRGBRISOt S1e te S18 $0.6
Slide 24: Dividend Policy
LANDAUER Dividend Policy Recent Dividend Payment ™ Board of Directors declared a regular quarterly cash dividend of $0.55 per share for the first quarter of fiscal 2014 — This represents an annual rate of $2.20 per share, consistent with fiscal 2013 levels — For the fourth fiscal quarter, the divide
Slide 25: Appendix
LANDAUER Respect Innovation Honesty Reliability Appendix
Slide 26: Landauer I/T Org
LANDAUER Landauer I/T Org: Basis of Support Ww Applications {since 2007) v | Infrastructure ==} {since 2007) LDR IT Evolution: 2006 - 2013 2003 2005 2007 2009 2010 2011 2012 2013 Luxel+ InlightProduct : *COMETProgram iFirst ILS Software «Nagase Landauer i * COMET Phase 2.0} *COMET Phase 3.0, } * Lan
Slide 27: LDR Corporate Evolution
LANDAUER Bill Saxelbynamed Presidentand CEO Acquired I21 Medical Products: Genesis of Medical Products Segment Physics Solutions: Acquired Global ( Genesis of Medical Physics Segment Inbight product technology released Reported FY'06 First launch o Raised annual dividend Revenue of $79M rate from $2